Virtual Peer-to-peer Support Programme for Carers of MND

Amyotrophic Lateral Sclerosis Clinical Trial

Official title:

A Virtual Peer-to-peer Support Programme for Family Caregivers of Individuals With Motor Neurone Disease at Risk of Becoming or Currently Technology-dependent: Randomised Controlled Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04695210
• Other study ID #: 292922
• Status: Recruiting
• Phase: N/A
• Start date: August 15, 2022
• Est. completion date: December 31, 2024

Study information

• Verified date: April 2023
• Source: King's College London
• Contact: Louise Rose, PhD
• Phone: +44 2078383616
• Email: louise.rose[@]kcl.ac.uk
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Background/scope There is growing recognition that family caregiving is a serious public health issue requiring supportive interventions. Family caregivers play an essential role in sustaining a stable environment enabling individuals with motor neurone disease (MND) that are technology dependent to live at home. The family caregivers can experi¬ence exceptional burden and significant decline in psychological wellbeing due to MND's rapid and pro¬gressive nature with profoundly debilitating effects and intensive support needs. Dependence on assistive technology adds an additional level of complexity to family caregiving due to the need to learn how to operate and troubleshoot medical devices, train other caregivers, and negotiate appointments with new specialties within the healthcare system. Despite the recognized impact of caregiving for individuals with MND, data are scarce as to effective interventions that provide direct practical and psychosocial supports. Difficulty accessing support may increase psychological distress. As the burden of caring increases due to disease progression and increasing technology dependence, access to existing informal support networks may diminish. Online peer support using virtual modalities is a flexible and low cost form of support. Peers, people who have experienced the same health problem and have similar characteristics as support recipients, can be a key source of emotional, informational, and affirmational support. Peer support improves psychological well-being of caregivers of people with conditions such as dementia, cancer, and brain injury. Although peer support programmes for family caregivers of people with MND exist, data as to their efficacy are limited. Therefore, we have developed an online peer support programme, completed beta and usability testing and now propose to test the effect on caregiver psychological wellbeing and caregiver burden. Aim/research question(s) Overall aim: to determine the efficacy of a 12-week online peer support programme on family caregiver psychological health and caregiver burden. Primary research question: What is the effect of the online peer support programme on psychological distress measured using the Hospital Anxiety and Depression Scale (HADS)? Secondary research questions: 1. What is the effect on positive affect, caregiver burden, caregiving mastery, caregiving personal gain, and coping? 2. How do participants use the programme (fidelity and reach)? 3. What is the perceived usability and acceptability? Methods The investigators will conduct a parallel group randomised controlled trial with participants allocated to 12-week access to the online peer support programme or a usual care control group. The investigators will enrol family caregivers of an individual with MND who is referred for consideration or receiving any of the following 1. assisted ventilation 2. cough assist 3. gastroscopy and enteral feeding i.e., entering King's clinical staging Stage 4A: nutritional support; or Stage 4B: respiratory support [51]: The 12-week peer-to-peer support programme entails: 1. audio, video, or text private messaging; 2. synchronous weekly chat; 3. asynchronous discussion forum; and 4. informational resources. The investigators will collect demographic and caregiving data including the Caregiver Assistance Scale and Caregiving Impact Scale, and caregiver measures (HADS, Positive and Negative Affect Schedule, Zarit Burden Interview, Pearlin Mastery Scale, Personal Gain Scale, Brief COPE) at baseline and programme completion. The investigators will download use of online peer support programme features, assess usability, and conduct semi-structured interviews to explore acceptability using the Theoretical Framework of Acceptability. To test for a medium size effect (d=0.5), at 5% level of significance (2-sided) with power 80%, 64 participants are required in each arm (128 total). Adjusting for 20% attrition requires 154 participants. Proposed findings The proposed study will demonstrate the effect of a online peer support programme on psychological distress, positive affect, caregiving burden, mastery, personal gain and coping. Data on programme fidelity will enable the investigators to objectively assess acceptability and interpret study results. Data on usability and acceptability will inform future scalability of the online peer support programme outside of the trial both nationally and internationally, and to other family caregiver populations.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 154
• Est. completion date: December 31, 2024
• Est. primary completion date: December 31, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

1. age = 18 years;

2. family/informal caregiver of an individual with MND living at home who is referred for consideration or receiving any of the following i.e., entering King's clinical staging

Stage 4A: nutritional support; or Stage 4B: respiratory support [51]:

1. assisted ventilation

2. cough assist

3. gastroscopy and enteral feeding

3. able to speak/read English;

4. has access to a computer, tablet, or smartphone and the internet (we have the ability to provide loan 4G enabled tablets if required); and

5. consents to participation

Exclusion Criteria:

1. Actively receiving psychiatric/psychologist care identified through self-report.

Related Conditions & MeSH terms

• Amyotrophic Lateral Sclerosis
• Motor Neuron Disease

Intervention

Behavioral:
• Virtual peer-to-peer support
See arm description

Locations

Country	Name	City	State
United Kingdom	Bedfordshire Hospitals NHS Foundation Trust	Bedford
United Kingdom	Airedale NHS Foundation Trust	Bradford
United Kingdom	University Hospitals Sussex NHS Foundation Trust	Brighton
United Kingdom	Pilgrims Hospice	Canterbury
United Kingdom	Coventry Community Specialist Palliative Care Team	Coventry
United Kingdom	University Hospitals Coventry and Warwickshire NHS Trust	Coventry
United Kingdom	Ninewells Hospital	Dundee
United Kingdom	Royal Devon University Healthcare NHS Foundation Trust	Exeter
United Kingdom	Phyllis Tuckwell Hospice	Farnham
United Kingdom	Medway Community Healthcare	Gillingham
United Kingdom	Kingston Hospital NHS Foundation	Kingston upon Thames
United Kingdom	The Leicestershire & Rutland Organisation for the Relief of Suffering - LOROS	Leicester
United Kingdom	The Walton Centre NHS Foundation Trust	Liverpool
United Kingdom	Guy's and St Thomas' NHS Foundation Trust	London
United Kingdom	Lancashire Teaching Hospitals NHS Foundation Trust	Multiple Locations
United Kingdom	Marie Curie Hospice	Multiple Locations
United Kingdom	Nottinghamshire Healthcare NHS Foundation Trust	Multiple Locations
United Kingdom	Royal Stoke University Hospital/University Hospitals North	Multiple Locations
United Kingdom	Swansea Bay University Health Board	Multiple Locations
United Kingdom	University Hospitals Plymouth NHS trust	Plymouth
United Kingdom	Sheffield Teaching Hospitals NHS Foundation Trust	Sheffield
United Kingdom	Severn Hospice	Shrewsbury
United Kingdom	St Margaret's Hospice	Taunton
United Kingdom	Hounslow and Richmond Community Healthcare	Teddington
United Kingdom	Compton Care	Wolverhampton

Sponsors (4)

Lead Sponsor	Collaborator
King's College London	Guy's and St Thomas' NHS Foundation Trust, Marie Curie Charity, MND Association

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Usability	For those participants in the intervention arm, on programme completion we will also ask them to rate the usability of the virtual peer-to-peer support programme on a 9-point Likert scale ranging from difficult to easy.	At 12 weeks following programme completion
Other	Acceptability	Semi-structured qualitative interviews exploring perceived acceptability of the virtual peer-to-peer support programme following programme completion	After 12 weeks following programme completion
Primary	Hospital Anxiety and Depression Score (HADS)	Change in Hospital Anxiety and Depression Score from baseline to programme completion. The Hospital Anxiety and Depression Score Overall score ranges from 0 [best] to 21 [worst] with cutoff points of >7 (possible) and >10 (probable) indicating cases of anxiety or depression.	6 weeks & 12 weeks
Secondary	Positive and Negative Affect Schedule	10-item Positive Affect Scale of the Positive and Negative Affect Schedule from baseline to programme completion. Scores range from 10 to 50; higher scores indicate more psychological well-being.	12 weeks
Secondary	Zarit Burden Interview (ZBI)	Change in ZBI score from baseline to programme completion. The sum of scores ranges between 0 to 88. Higher scores indicate greater burden. Caregivers can be categorised as 'highly burdened' (score of = 24) and low burdened groups (score <24)	6 weeks & 12 weeks
Secondary	Pearlin Mastery Scale	Change in Pearlin Mastery Scale from baseline to programme completion. The Pearlin Mastery Scale is a 7 item scale with scores from 7 to 28. Higher scores indicate a greater sense of control over life.	12 weeks
Secondary	Brief-COPE (note COPE is not an abbreviation)	Change in Brief COPE from baseline to programme completion. 14 scales with 2 items (28 items in total. Scores on each scale range from 2 (minimum) to 8 (maximum). Higher scores indicate increased utilisation of that specific coping strategy.	12 weeks